CLSA Downgrades Telix Pharmaceuticals Ltd (TLX:AU) to Outperform (2)
- Microsoft (MSFT) Near Deal to Acquire Nuance (NUAN) - Report
- S&P 500, Dow climb for third day and close at records
- Tesla (TSLA) China Numbers 'Robust' - Wedbush
- Apple (AAPL) Shares Seen as 'Attractive' as Recent Checks Show Continuously Strong Demand - Citi
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
CLSA analyst Silvia Luo downgraded Telix Pharmaceuticals Ltd (TLX:AU) from Buy (1) to Outperform (2) with a price target of AUD4.30 (from AUD4.30).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Grupo Aeroportuario del Pacifico SAB de CV (GAPB:MM) (PAC) to Neutral
- Mahindra & Mahindra Financial Services Ltd. (MMFS:IN) PT Raised to INR167 at Goldman Sachs
- HDFC Bank Ltd (HDFCB:IN) (HDB) PT Raised to INR1,853 at Goldman Sachs